Asaya preps Series A to scale science-led skincare for melanin-rich skin in India
D2C skincare brand Asaya, targeting melanin-rich skin, is raising a Series A to fund R&D, clinical studies and offline retail expansion. It has raised ₹43 crore to date, crossed 5 lakh customers, and grown 5x in the past year, with Blinkit contributing 17% of revenue.
What happened
Indian skincare D2C startup Asaya, focused on melanin-rich skin, is preparing a Series A round to fund R&D, clinical studies and offline retail expansion. It
Key facts
- ₹43 crore raised to date
- 5 lakh customers
- grown 5x in past year
- Blinkit 17% of revenue
Why this matters
A fast-scaling, R&D-focused D2C skincare brand targeting melanin-rich Indian skin is an early acquisition or partnership target for beauty majors seeking demographic and clinical credibility.
What to watch
- Series A term sheet / close announcement and round size
- Blinkit revenue share trending above 20% (concentration flag)
- New melanin-focused launches from incumbent FMCG or Nykaa private label
- Monthly active customer retention and repeat-purchase rate
- First offline retail doors count and sell-through
- Announce Series A close with named lead investor and valuation
- Diversify channel mix: expand own website + add pharmacy/modern trade to reduce Blinkit reliance
- Publish clinical study data to differentiate on efficacy claims
- Launch offline pilot in tier-1 metros via beauty retail chains
- Broaden SKU range targeting specific melanin-rich skin concerns (hyperpigmentation, acne scars)